Peptide
Mepolizumab
Mepolizumab is used or studied for reduces eosinophils and related immune, inflamation and longevity goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Detail
Overview
Mepolizumab is used or studied for reduces eosinophils and related immune, inflamation and longevity goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Benefits, side effects, and protocols
Benefits list
- Reduces eosinophils
Side effects
- Headache
- injection site pain
Vendor protocol
- None listed
Clinical protocol
- None listed
Evidence
- High
- Eosinophilic asthma
Regulatory
- Fda Approved
- Prescription required
Research
Mechanisms
None Listed
Evidence notes
- High
- Eosinophilic asthma
Administration
InjectableSubcutaneous
Research links
Contraindications
- None listed
Components
- None listed
Regulatory data
- Fda Approved
- Prescription required
Aliases
- None listed
Related compounds
Half-life
How long does Mepolizumab stay in your system?
Half-life ≈ 16–22 days — see what remains after any number of days, and when it is practically cleared.
Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations. Sourcing Mepolizumab? Check your source before you use anything.